Log In
BCIQ
Print this Print this
 

AVB-620

  Manage Alerts
Collapse Summary General Information
Company Avelas Biosciences Inc.
DescriptionIV fluorescent protease-activated peptide
Molecular Target
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase I
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose lymph node metastases in breast cancer patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today